Medical device company Vertos
Medical Inc. has announced the release of positive results from its
U.S. IRB I Patient Outcomes Trial, a prospective, investigational review
board-approved, 75-patient study of mild
for the treatment of lumbar spinal stenosis (LSS). Six-week clinical
data have shown that patients treated with mild experience
statistically and clinically significant improvement in both pain and
functional ability. The data also confirmed mild’s safety, with
no reports of patient complications related to the procedure or the
devices.
“mild provides a valuable therapeutic option for suffering
patients, for whom we previously had only palliative treatments or open
surgery”
The six-week follow-up data were unveiled at a continuing medical
education (CME) meeting, chaired by Nagy Mekhail, M.D., Ph.D., at the 12th
Annual Cleveland Clinic Pain Management Symposium in Coronado, Calif. on
March 8.